ReviewCancer journal (Sudbury, Mass.)

HER2 and HER3 as Therapeutic Targets in Head and Neck Cancer.

Robert Saddawi-Konefka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.